Torrent Pharmaceuticals Ltd

Large Cap

Healthcare Sector

reflects a positive outlook for the share price

reflects a neutral outlook for the share price

reflects a negative outlook for the share price

The analysts information is for reference only and does not\n  represents an investment recommendation.

Analyst recommendation reflect the views of analysts who follow and write research reports.

Company Information is an introduction to the company’s business that details what it sell, how it was founded, what their mission is, how they manufacture or source their products, and why they serve customers.

Torrent Pharmaceuticals aims to raise ₹12,500 crore through bond sales to acquire a controlling stake in JB Chemicals, boosting its market share to fifth place.

Torrent Pharma Raises Funds for JB Chemicals Acquisition - 08 Jan, 2026

Torrent Pharmaceuticals' board has approved a plan to raise up to Rs 12,500 crore through the issuance of secured non-convertible debentures via private placement. This move aims to enhance liquidity and support expansion efforts.

Torrent Pharma Plans Rs 12,500 Crore Fundraise - 05 Jan, 2026

Torrent Pharmaceuticals will consider issuing secured NCDs on January 5, 2026. The company reported a 14% revenue increase to Rs 3,302 crore in Q2 FY25, with a gross profit margin of 76%. The stock fell 0.34% to Rs 3,807.60 on the BSE.

Torrent Pharma Plans NCD Issuance Amid Growth - 31 Dec, 2025

Price to Earnings Ratio or Price to Earnings Multiple is the ratio of the share price of a stock to its earnings per share (EPS). It provides an indication of whether a stock at its current market price is expensive or cheap.

The price/earnings-to-growth ratio, or the PEG ratio, is a metric that helps investors value a stock by taking into account a company's market price, its earnings, and its future growth prospects.

Enterprise value (EV) is the total value of a company, defined in terms of its financing. It includes both the current share price (market capitalization) and the cost to pay off debt (net debt, or debt minus cash).

Alpha measures the amount that the investment has returned in comparison to the market index or other broad benchmark that it is compared against.

Beta measures a stock's volatility, the degree to which its price fluctuates in relation to the overall stock market. In other words, it gives a sense of the stock's risk compared to that of the greater market.

Dividend yield measures the quantum of earnings by way of total dividends that investors make by investing in that company.

The debt-to-total-assets ratio shows how much of a business is owned by creditors (people it has borrowed money from) compared with how much of the company's assets are owned by shareholders.

Operating cash flow (OCF) is a measure of the amount of cash generated by a company's normal business operations. Operating cash flow indicates whether a company can generate sufficient positive cash flow to maintain and grow its operations.

This widget shows the information about the stock's peers in consideration along with the different data for those peers so that the user can compare the stock with the other similar stock and invest accordingly.

Promoter holding is the amount of share of the company that is owned by the promoters. The promoters are the company's founders, who hold a majority stake in the company's capital.

A foreign institutional investor (FII) is an investor or investment fund investing in a country outside of the one in which it is registered or headquartered.

A mutual fund is a pool of money managed by a professional Fund Manager. It is a trust that collects money from a number of investors who share a common investment objective and invests the same in equities, bonds, money market instruments, and other securities.

Retail investors execute their trades through traditional or online brokerage firms or other types of investment accounts. Retail investors purchase securities for their own personal accounts and often trade in dramatically smaller amounts as compared to institutional investors.

This widget shows the bifurcation of stocks based on the percentage of stake with the different types of shareholders.

This widget will help value the stock based on the Price to Earning ratio of the stock and compare the valuation with the industry value and other similar stocks. It even shows the timeline of the valuation of the stock and its highest and lowest valuation over time.
A Time Series data is provided which compares the historical stock PE with Industry PE over the period of 5 years.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

Netprofit is up for the last 3 quarters, 498.0 Cr → 591.0 Cr (in ₹), with an average increase of 8.2% per quarter

This section gives you an insight into how the profit for the company has been for the last few quarters.

Profit Spike

In the last 3 years, TORNTPHARM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

This section gives you an insight into why this company has been the best in its industry for the last 3 years.

Best in 3 Years

Mutual Funds have increased holdings from 4.95% to 5.12% in Sep 2025 quarter

This section gives you an insight into how the Mutual Funds Holding has changed for the stock over last few quarters.

MF Holding Up

In the last 7 days, TORNTPHARM stock has moved up by 2.4%

This section gives you an insight into the price movement of the stock for the last few quarters.

Price Rise

In the last 1 year, TORNTPHARM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

This section gives you an insight into why this company has been the best in its industry for the last 1 year.

Best in 1 Year

Revenue is up for the last 4 quarters, 2.84K Cr → 3.27K Cr (in ₹), with an average increase of 4.6% per quarter

This section gives you an insight into how the revenue of the company has moved for the last few quarters.

Revenue Rich

Promoters holdings remained unchanged at 68.31% of holdings in Sep 2025 quarter

This section gives you an insight into how the Promoter Holding has changed for the stock over the last few quarters.

Promoter Holding Unchanged

Retail Investor have decreased holdings from 6.94% to 6.49% in Sep 2025 quarter

This section gives you an insight into how the Retail Investors Holding has changed for the stock over last few quarters.

Retail Holding Down

Foreign Institutions have decreased holdings from 16.09% to 15.92% in Sep 2025 quarter

This section gives you an insight into how the FII Holding has changed for the stock over last few quarters.

FII Holding Down

Nifty Next 50

NIFTY PHARMA

S&P BSE 100 LargeCap TMC

Nifty100 Low Volatility 30

BSE Healthcare

BSE 500

Nifty 200

S&P BSE Largecap

Nifty Healthcare

S&P BSE Momentum

NIFTY 100

Nifty LargeMidcap 250

S&P BSE Dividend Stability

S&P BSE Quality

BSE 200

Nifty100 Eq Weig

S&P BSE 250 LargeMidCap

Nifty 500

HDFC Large Cap Fund -Direct Plan - Growth Option

Axis Large Cap Fund Direct Plan Growth

Franklin India Large Cap Fund Direct Growth

UTI Flexi Cap Fund - Growth Option - Direct

Canara Robeco Large Cap Fund Direct Plan Growth

Torrent Pharmaceuticals Ltd’s net profit jumped 30.46% since last year same period to ₹591.00Cr in the Q2 2025-2026. On a quarterly growth basis, Torrent Pharmaceuticals Ltd has generated 7.85% jump in its net profits since last 3-months.

Torrent Pharmaceuticals Ltd Earnings Results

In the quarter ending March 2025, Torrent Pharmaceuticals Ltd has declared dividend of ₹6.00 per share on 20 May 2025 - translating a dividend yield of 0.96%.

Name	Value	Action
MACD level (12,26)	-3.12	Bearish
CCI (20)	325.53	Bearish
RSI (14)	30.4	Neutral
Momentum (10)	-11.8	Neutral
ADI (14)	26.16	Bearish
Ultimate Oscillator (7,14,28)	14.09	Bearish

Name	Value	Action
SMA (20)	3965.4	Bearish
EMA (20)	3964.4	Bearish
VWMA (20)	3963.67	Bearish
SMA (50)	3968.69	Bearish
EMA (50)	3967.48	Bearish
SMA (200)	3976.29	Bearish
EMA (200)	3976.81	Bearish
KAMA (200)	3968.47	Bearish
DEMA (200)	3963.88	Bearish

Torrent Pharmaceuticals Ltd (TORNTPHARM)

Summary

Overall

Oscillators

Moving Averages